Person

Paul R. Flynn

Formerly EVP Global Revenue, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$2.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    EVP Global Revenue
    Apr 2021 – last filing Dec 2023

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 17, 2023DXCMSale2,781$120.00$334K
Mar 13, 2023DXCMSale2,782$106.27$296K
Dec 8, 2022DXCMSale8,988$123.50$1.1M
Sep 10, 2021DXCMSale626$558.33$350K
Sep 9, 2021DXCMSale9$541.76$5K
Sep 9, 2021DXCMSale743$541.36$402K
Apr 15, 2021DXCMSale758$400.00$303K

SEC reporting-owner ID (CIK) 1850141 · all filings on EDGAR